PlainBillCongress, translated.Legislation. Context. Public interest.Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 493.
Congressional Research Service
Version 00 · Introduced in House · Jun 18, 2002
Medicare Modernization and Prescription Drug Act of 2002 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to add a new part D (Voluntary Prescription Drug Benefit Program) under which each individual who is entitled to benefits under Medicare part A (Hospital Insurance) or enrolled under Medicare part B (Supplemental Medical Insurance) is entitled to obtain qualified prescription drug coverage by electing to enroll: (1) in a plan that provides qualified prescription drug coverage under the Medicare+Choice program under SSA title XVIII part C (Medicare+Choice) (M+C); or (2) in a prescription drug plan (PDP) under part D if the individual is not enrolled in a M+C plan providing qualified prescription drug coverage.Outlines standard coverage benefit packages for FY 2005. Includes for the standard package an annual deductible of $250, and requires insurers under such package to cover 80 percent of enrollees drug costs from $251 to $1,000, then 50 percent of such costs between $1,001 and the initial coverage limit of $2,000. Requires enrollees to cover all costs between $2,001 and $4,500, and Medicare to cover the entire cost once the beneficiary has reached the $4,500 catastrophic limit. Prescribes a formula for adjustment of the deductible and thresholds for years after 2005.Establishes a competitive bidding process for negotiating the terms and conditions of PDP sponsors.Provides for full premium subsidy and reduction of cost-sharing for individuals with incomes below 150 percent of the Federal poverty level. Contains subsidy payments for qualifying entities to promote the participation of PDP sponsors.Amends SSA title XVIII part C to: (1) provide for the offering of qualified prescription drug coverage under M+C; and (2) create a competitive bidding program for M+C organizations.Sets out a new Medicare prescription drug discount card endorsement program under Medicare.Makes a number of other changes with regard to Medicare: (1) part A concerning rural health care, inpatient hospital services, skilled nursing facility services, and hospices; (2) part B concerning physicians services and other services; and (3) part A and B concerning home health services, direct graduate medical education, and other provisions.Amends SSA title XVIII part E (Miscellaneous) (previously part D) to include a number of regulatory, contracting, and administrative changes.Establishes the National Bipartisan Commission on the Future of Medicaid.Amends the Federal Food, Drug, and Cosmetic Act to add requirements for interstate Internet sellers of prescription drugs.Establishes within the Office of the Director of the National Institutes of Health the Office of Rare Diseases.Amends the Internal Revenue Code to make specified health-care related tax changes.
People & committees
Rep. Johnson, Nancy L. [R-CT-6] · R–CT
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 493.
Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Received in the Senate.
On passage Passed by recorded vote: 221 - 208 (Roll no. 282). (text: CR H4182-4269)
House roll call 282 · Individual votesMotion to reconsider laid on the table Agreed to without objection.
Passed/agreed to in House: On passage Passed by recorded vote: 221 - 208 (Roll no. 282).(text: CR H4182-4269)
House roll call 282 · Individual votesOn motion to recommit with instructions Failed by recorded vote: 204 - 223 (Roll no. 281).
House roll call 281 · Individual votesMr. Gephardt moved to recommit with instructions to Ways and Means and Energy and Commerce. (consideration: CR H4297-4320; text: CR H4297-4318)
DEBATE - The House proceeded with two hours of debate on H.R. 4954.
Rule provides for consideration of H.R. 4954 with 2 hours of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Bill is closed to amendments.
Considered under the provisions of rule H. Res. 465. (consideration: CR H4182-4320)
Rule H. Res. 465 passed House.
Rules Committee Resolution H. Res. 465 Reported to House. Rule provides for consideration of H.R. 4954 with 2 hours of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. Measure will be considered read. Bill is closed to amendments.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 107-539, Part I.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 107-539, Part I.
Referred to the Subcommittee on Health.
Ordered to be Reported (Amended).
Committee Consideration and Mark-up Session Held.
Referred, pursuant to the order of the House of June 17, 2002, jointly to the Committees on Energy and Commerce and Ways and Means.
Referred, pursuant to the order of the House of June 17, 2002, jointly to the Committees on Energy and Commerce and Ways and Means.
Referred, pursuant to the order of the House of June 17, 2002, jointly to the Committees on Energy and Commerce and Ways and Means.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
Source last updated: Apr 7, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.4954 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.4954 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.4954 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.4954 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.